Artelo Biosciences, Inc. ( ARTL) - Key Metrics
ARTL Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.89 | -$1.86 | -$1.86 |
| 2026Q1 | $0 | -$4 | -$1.61 | -$1.61 |
| 2025Q4 | $0 | -$1.77 | -$1.24 | -$1.24 |
| 2025Q3 | $0 | -$1.32 | -$1.48 | -$1.48 |
| 2025Q2 | $0 | -$1.87 | -$0.30 | -$0.30 |
ARTL Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.31 |
| 2026Q1 | 0% | -0.47 |
| 2025Q4 | 0% | -0.15 |
| 2025Q3 | 0% | -0.87 |
| 2025Q2 | 0% | -1.77 |
ARTL
Price: $0.73
52 week price:
Earnings Per Share: -11.23 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 36149
Market Capitalization: 3.4 million